Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients

NCT00117507 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes
Iron Overload

Interventions

DRUG: Deferasirox

Sponsor

Novartis Pharmaceuticals